SAN MATEO, Calif., Aug. 22 /PRNewswire-FirstCall/ -- BioForm Medical, Inc.
(Nasdaq: BFRM) announced that on Thursday, September 4, 2008, it will report
its financial results for its fourth quarter and fiscal year ended June 30,
2008. The Company will issue the earnings press release after the NASDAQ
Global Market closes and will hold a conference call with investors at 2:00
p.m. Pacific Time (5:00 p.m. Eastern Time).
BioForm Medical Chief Executive Officer Steve Basta and Chief Financial
Officer Derek Bertocci will discuss the Company's results for the fourth
quarter and fiscal year ended June 30, 2008. The conference call will be
webcast live on the Investor Relations section of BioForm Medical's website at
http://www.bioform.com. The online archive of the broadcast will be available
approximately 90 minutes after the live call and will continue to be available
for four weeks.
The conference call may be accessed by dialing 888-287-5530 for callers in
the U.S. and 719-785-1768 for international callers. Please notify the
operator that you would like to join "BioForm Medical's Fourth Quarter &
Fiscal 2008 Earnings Call" and provide the participant code "2257477", if
prompted.
About BioForm Medical, Inc.:
BioForm Medical, Inc. is a medical aesthetics company headquartered in San
Mateo, California, developing products that enhance aesthetic procedures
performed in dermatology and plastic surgery practices. BioForm Medical's lead
product is Radiesse(R) dermal filler, a long-lasting filler for use in facial
aesthetics. BioForm Medical is developing several future aesthetics products,
including a radiofrequency treatment to reduce nerve function in the forehead,
a sclerotherapy treatment for spider veins, and a surgical adhesive for brow
lifts. For more information about BioForm, please visit
http://www.bioform.com.
Contact:
Adam Gridley
650.286.4025
Vice President, Corporate Development
BioForm Medical, Inc.
SOURCE BioForm Medical, Inc.